Nationwide Population Based Study of Infections after Transrectal Ultrasound Guided Prostate Biopsy
- 1 October 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 192 (4) , 1116-1122
Abstract
Transrectal ultrasound guided biopsy is the gold standard for detecting prostate cancer but international reports suggest that increasing risks are associated with the procedure. We estimated incidence and risk factors for infection after prostate biopsy as well as 90-day mortality using a nationwide Swedish sample. We performed a population based study of 51,321 men from PCBaSe between 2006 and 2011. Primary outcome measures were dispensed prescriptions of antibiotics for urinary tract infection and hospitalization with a discharge diagnosis of urinary tract infection. Multivariable logistic regression was used to examine risk factors for infection in men who underwent prostate biopsy. During the 6 months before biopsy the background incidence of urinary tract infection was approximately 2%. Within 30 days after biopsy 6% of the men had a dispensed prescription for urinary tract antibiotics and 1% were hospitalized with infection. The strongest risk factors for an antibiotic prescription were prior infection (OR 1.59, 95% CI 1.45-1.73), high Charlson comorbidity index (OR 1.25, 95% CI 1.11-1.41) and diabetes (OR 1.32, 95% CI 1.17-1.49). Risk of an antibiotic prescription after biopsy decreased from 2006 to 2011 (OR 0.79, 95% CI 0.70-0.90) but the risk of hospital admission increased (OR 2.14, 95% CI 1.58-2.94). No significant increase was observed in 90-day mortality. Severe infections with hospitalization after prostate biopsy are increasing in Sweden. The risk of post-biopsy infection is highest in men with a history of urinary tract infection and those with significant comorbidities.Keywords
This publication has 16 references indexed in Scilit:
- Infectious Complications and Hospital Admissions After Prostate Biopsy in a European Randomized TrialEuropean Urology, 2012
- Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0International Journal of Epidemiology, 2012
- Complications After Prostate Biopsy: Data From SEER-MedicareJournal of Urology, 2011
- Impact of Comorbidity on Survival Among Men With Localized Prostate CancerJournal of Clinical Oncology, 2011
- Increasing Hospital Admission Rates for Urological Complications After Transrectal Ultrasound Guided Prostate BiopsyJournal of Urology, 2010
- Reliability of death certificates in prostate cancer patientsScandinavian Journal of Urology and Nephrology, 2008
- Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005Scandinavian Journal of Urology and Nephrology, 2007
- Single-Dose Antibiotic Prophylaxis in Core Prostate Biopsy: Impact of Timing and Identification of Risk FactorsEuropean Urology, 2006
- The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiology and Drug Safety, 2006
- Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening programUrology, 2002